AARDEX Group

Company News

Press Release

AARDEX Group and Compliance Meds Technologies sign collaboration agreement

AARDEX Group, the global leader in medication adherence solutions, has today announced a collaboration agreement with Compliance Meds Technologies (CMT), a mobile-health technology solutions provider. In this cooperation, the partners will combine the AARDEX MEMS® Adherence Software with CMT’s CleverCap® … Read More

Medication Adherence in Chronic Disease Management

Innovative Approaches to Enhance and Measure Medication Adherence in Chronic Disease Management

Medication adherence is a vital component in managing chronic diseases effectively. However, it remains a significant challenge, with non-adherence rates reaching up to 50% among patients. This lack of adherence results in poor health outcomes and increased burdens on healthcare … Read More

Is the data from randomised clinical trials random to the point of pointless?

In a recent paper titled ‘The impacts of undetected nonadherence in phase II, III and post-marketing clinical trials: An overview’ the authors detailed the findings of a research project which aimed to provide an overview of the consequences of unrecognized … Read More

AARDEX Group and SHL Medical forge strategic alliance to interface medication adherence software with connected self-injection solutions

AARDEX Group Belgium – SHL Medical, a world-leading provider of drug delivery devices, and AARDEX Group, the global leader in medication adherence solutions, today announced their strategic partnership aimed at delivering an end-to-end solution for pharma customers seeking to demonstrate … Read More

Challenging the Status Quo for Measuring Medication Adherence in Clinical Trials

Poor adherence to the investigational product can bring even the most carefully planned clinical trial to its knees. It is time to accept that traditional approaches such a pill count do not work. We need to upset the status quo … Read More

AARDEX Group and medmix Join Forces to Improve Self-Administration of Injectable Drugs in Clinical Trials

Belgium – medmix Drug Delivery (Haselmeier) and AARDEX Group announced today a collaboration, combining Haselmeier´s D-Flex™ Logbook with AARDEX Group’s Medication Adherence software and hardware ecosystem.  Clinical testing during new drug development is costly and time intensive for pharmaceutical and … Read More

Clinical Trials Europe 2022: Learn About Unlocking Medication Adherence Insights to Enhance Drug Development

Poor medication adherence in clinical trials may be a long-standing challenge, but advanced approaches and technologies are finally cutting it down to size. Join AARDEX’s scientific lead at the 21st Clinical Trials Europe event to find out how. Bernard Vrijens and … Read More

Therapeutic Drug Monitoring: The Difference Between Accurate and Reliable

Adherence to medication during clinical trials is a problem of striking magnitude, and one that researchers have employed therapeutic drug monitoring (TDM) to solve for years. But the approach, which measures the level drug or drug metabolites in patients’ blood, … Read More

Measure to Manage: How Data-Driven Feedback Drives up Patient Adherence in Clinical Trials

Every clinical trial participant with poor medication adherence will have their own set of complex reasons for not taking their medications as prescribed – meaning there is no one size fits all solution. Instead, sponsors should take a data-driven approach … Read More

Setting the Stage for Better Medication Adherence in Clinical Trials

When clinical trial participants do not follow the dosing protocol, it can result in an underestimation of a drug’s therapeutic effect. With inability to demonstrate efficacy being the leading cause of study failure worldwide1, it’s an issue sponsors cannot afford … Read More